The non-palindromic adaptor-PCR method for the identification of the T-cell receptor genes of an interferon-λ-secreting T-cell hybridoma specific for trans-sialidase, an immunodominant Trypanosoma cruzi antigen

Brazilian Journal of Medical and Biological Research

Volumn 39, Issue 3, 2006, Pages 345-354

  Hiyane, M I ^a   Boscardin, S B ^a   Rodrigues, M M ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

NPA PCR method; T cell receptor; Trans sialidase; Trypanosoma cruzi

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; COMPLEMENTARY DNA; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; PARASITE ANTIGEN; SIALIDASE; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; BETA CHAIN; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE ISOLATION; GENE SEQUENCE; GENETIC CODE; HYBRIDOMA; IMMUNOSTIMULATION; MOLECULAR CLONING; MOUSE; NON PALINDROMIC ADAPTOR POLYMERASE CHAIN REACTION; NONHUMAN; POLYMERASE CHAIN REACTION; T LYMPHOCYTE RECEPTOR GENE; TRANSGENIC MOUSE; TRANSGENICS; TRYPANOSOMA CRUZI;

ANIMALIA; MUS MUSCULUS; TRYPANOSOMA CRUZI;

EID: 33644815011     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2006000300005     Document Type: Article

References (28)

1. Furtado GC, Olivares-Villagomez D, Curotto de Lafaille MA et al. (2001). Regulatory T cells in spontaneous autoimmune encephalomyelitis. Immunological Reviews, 182: 122-134.
2. Haskins K (2004). T-cell receptor transgenic (TCR-Tg) mice from two diabetogenic CD4+ islet-antigen-specific T-cell clones. Journal of Autoimmunity, 22: 107-109.
3. Chen J, Eisen HN & Kranz DM (2003). A model T-cell receptor system for studying memory T-cell development. Microbes and Infection, 5: 233-240.
4. Bumann D (2003). T cell receptor-transgenic mouse models for studying cellular immune responses to Salmonella in vivo. FEMS Immunology and Medical Microbiology, 37: 105-109.
5. Morrot A & Zavala F (2004). Effector and memory CD8+ T cells as seen in immunity to malaria. Immunological Reviews, 201: 291-303.
6. Ganss R, Limmer A, Sacher T et al. (1999). Autoaggression and tumor rejection: it takes more than self-specific T-cell activation. Immunological Reviews, 169: 263-272.
7. Chen PF & Platsoucas CD (1992). Development of the non-palindromic adaptor polymerase chain reaction (NPA-PCR) for the amplification of alpha- and beta-chain T-cell receptor cDNAs. Scandinavian Journal of Immunology, 35: 539-549.
8. Lin WL, Kuzmak J, Pappas J et al. (1998). Amplification of T-cell receptor alpha- and beta-chain transcripts from mouse spleen lymphocytes by the nonpalindromic adaptor-polymerase chain reaction. Hematopathology and Molecular Hematology, 11: 73-88.
9. Slachta CA, Jeevanandam V, Goldman B et al. (2000). Coronary arteries from human cardiac allografts with chronic rejection contain oligoclonal T cells: persistence of identical clonally expanded TCR transcripts from the early post-transplantation period (endomyocardial biopsies) to chronic rejection (coronary arteries). Journal of Immunology, 165: 3469-3483.
10. Oleszak EL, Lin WL, Legido A et al. (2001). Presence of oligoclonal T cells in cerebrospinal fluid of a child with multiphasic disseminated encephalomyelitis following hepatitis A virus infection. Clinical and Diagnostic Laboratorial Immunology, 8: 984-992.
11. Sakkas LI, Xu B, Artlett CM et al. (2002). Oligoclonal T-cell expansion in the skin of patients with systemic sclerosis. Journal of Immunology, 168: 3649-3659.
12. Xu B, Sakkas LI, Goldman BI et al. (2003). Identical alpha-chain T-cell receptor transcripts are present on T cells infiltrating coronary arteries of human cardiac allografts with chronic rejection. Cellular Immunology, 225: 75-90.
13. Morel CM & Lazdins J (2003). Chagas disease. Nature Reviews. Microbiology, 1: 14-15.
14. Tarleton RL (2003). Chagas disease: a role for autoimmunity? Trends in Parasitology, 19: 447-451.
15. Sartori AM, Shikanai-Yasuda MA, Amato Neto V et al. (1998). Follow-up of 18 patients with human immunodeficiency virus infection and chronic Chagas' disease, with reactivation of Chagas' disease in three patients. Clinical Infectious Diseases, 26: 177-179.
16. Soares MB, Silva-Mota KN, Lima RS et al. (2001). Modulation of chagasic cardiomyopathy by interleukin-4: dissociation between inflammation and tissue parasitism. American Journal of Pathology, 159: 703-709.
17. Pontes-de-Carvalho L, Santana CC, Soares MB et al. (2002). Experimental chronic Chagas' disease myocarditis is an autoimmune disease preventable by induction of immunological tolerance to myocardial antigens. Journal of Autoimmunity, 18: 131-138.
18. Schenkman S, Eichinger D, Pereira ME et al. (1994). Structural and functional properties of Trypanosoma trans-sialidase. Annual Review of Microbiology, 48: 499-523.
19. Cazzulo JJ & Frasch ACC (1992). SAPA/trans-sialidase and cruzipain: two antigens from Trypanosoma cruzi contain immunodominant but enzymatically inactive domains. FASEB Journal, 6: 3259-3264.
20. Leguizamon MS, Campetella O, Russomando G et al. (1994). Anti-bodies inhibiting Trypanosoma cruzi trans-sialidase activity in sera from human infections. Journal of Infectious Diseases, 170: 1570-1574.
21. Pereira-Chioccola VL, Schenkman S & Kloetzel JK (1994). Sera from chronic chagasic patients and rodents infected with Trypanosoma cruzi inhibit trans-sialidase by recognizing its amino-terminal and catalytic domain. Infection and Immunity, 62: 2973-2978.
22. Pereira-Chioccola VL, Fragata-Filho AA, Levy AM et al. (2003). Enzyme-linked immunoassay using recombinant trans-sialidase of Trypanosoma cruzi can be employed for monitoring of patients with Chagas' disease after drug treatment. Clinical and Diagnostic Laboratory Immunology, 10: 826-830.
23. Ribeirao M, Pereira-Chioccola VL, Renia L et al. (2000). Chagasic patients develop a type 1 immune response to Trypanosoma cruzi trans-sialidase. Parasite Immunology, 22: 49-53.
24. Costa F, Franchin G, Pereira-Chioccola VL et al. (1998). Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cnizi infection in mice. Vaccine, 16: 768-774.
25. + T-cell apitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi gene. Infection and Immunity, 69: 5477-5486.
26. Fralish BH & Tarleton RL (2003). Genetic immunization with LYT1 or a pool of trans-sialidase genes protects mice from lethal Trypanosoma cruzi infection. Vaccine, 21: 3070-3080.
27. Ribeirão M, Pereira-Chioccola VL, Eichinger D et al. (1997). Temperature differences for trans-glycosylation and hydrolysis reaction reveal an acceptor binding site in the catalytic mechanism of Trypanosoma cruzi trans-sialidase. Glycobiology, 7: 1237-1246.
28. Rodrigues MM, Ribeirão M, Pereira-Chioccola VL et al. (1999). Predominance of CD4 Th1 and CD8 Tc1 cells revealed by characterization of the cellular immune response generated by immunization with a DNA vaccine containing a Trypanosoma cruzi gene. Infection and Immunity, 67: 3855-3863.